Filing Details
- Accession Number:
- 0001773751-24-000365
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-19 18:08:34
- Reporting Period:
- 2024-11-18
- Accepted Time:
- 2024-11-19 18:08:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1773751 | Hims & Hers Health Inc. | HIMS | Services-Offices & Clinics Of Doctors Of Medicine (8011) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1837815 | Melissa Baird | 2269 Chestnut Street, #523 San Francisco CA 94123 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2024-11-18 | 58,750 | $0.40 | 688,916 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2024-11-18 | 6,199 | $20.60 | 682,717 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2024-11-18 | 11,426 | $21.30 | 671,291 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2024-11-18 | 12,601 | $20.48 | 658,690 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2024-11-18 | 28,524 | $21.29 | 630,166 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Stock Option (right to buy) | Disposition | 2024-11-18 | 58,750 | $0.00 | 58,750 | $0.40 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
343,178 | 2028-03-28 | No | 4 | M | Direct |
Footnotes
- The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 30, 2024 by the Reporting Person.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.97 - $20.965. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.98 - $21.76. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.89 - 20.885. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.905 - $21.825. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested.